E Fund Management Co. Ltd. Increases Stake in Teleflex Incorporated (NYSE:TFX)

E Fund Management Co. Ltd. increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 138.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,940 shares of the medical technology company’s stock after buying an additional 1,127 shares during the period. E Fund Management Co. Ltd.’s holdings in Teleflex were worth $345,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Apollon Wealth Management LLC increased its stake in shares of Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after buying an additional 55 shares during the period. SRS Capital Advisors Inc. increased its stake in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 60 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Teleflex by 0.4% during the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after buying an additional 65 shares during the period. Tokio Marine Asset Management Co. Ltd. increased its stake in shares of Teleflex by 4.5% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after buying an additional 66 shares during the period. Finally, HighTower Advisors LLC increased its stake in shares of Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after buying an additional 66 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE TFX opened at $140.24 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company has a market cap of $6.50 billion, a PE ratio of 27.88, a P/E/G ratio of 1.73 and a beta of 1.21. The business has a 50-day simple moving average of $171.13 and a two-hundred day simple moving average of $201.30. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.90.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Analysts Set New Price Targets

Several equities analysts have recently commented on TFX shares. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Bank of America downgraded Teleflex from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and dropped their price objective for the company from $220.00 to $155.00 in a research report on Friday, February 28th. Wells Fargo & Company dropped their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.